Request Demo
Last update 20 Dec 2025
RC-98
Last update 20 Dec 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms RC 98, RC98 |
Target |
Action inhibitors |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with RC-98NCT05514158
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG).
CTR20192459
评价注射用RC98治疗晚期恶性实体肿瘤受试者的安全性、耐受性、药代动力学及有效性的I/IIa期临床研究
[Translation] A Phase I/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of RC98 for injection in the treatment of subjects with advanced malignant solid tumors
NCT04190823
A Phase I Study to Evaluate the Safety,Tolerability and Pharmacokinetics of RC98 For Injection in Subjects With Advanced Malignant Solid Tumors
100 Clinical Results associated with RC-98
Login to view more data
100 Translational Medicine associated with RC-98
Login to view more data
100 Patents (Medical) associated with RC-98
Login to view more data
100 Deals associated with RC-98
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 14 Oct 2020 | |
| HER2-expressing Gastric Adenocarcinoma | Phase 1 | China | 28 Sep 2022 | |
| Microphthalmia, Syndromic 3 | Phase 1 | China | 28 Sep 2022 | |
| HER2-positive gastric cancer | Phase 1 | China | 16 Sep 2022 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 15 Mar 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free